Medicenna Therapeutics Corp Financial Overview
Medicenna Therapeutics Corp's market cap is currently C$69.41M. The company's EPS TTM is C$-0.06; its P/E ratio is -5.96; Medicenna Therapeutics Corp is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.06. See an overview of income statement, balance sheet, and cash flow financials.
